The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CRISPR Genome Editing Market Research Report 2024
Synopsis
CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR.
The global CRISPR Genome Editing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR Genome Editing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR Genome Editing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRISPR Genome Editing in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRISPR Genome Editing include Editas Medicine, CRISPR Therapeutics, Horizon Discovery, Sigma-Aldrich, Genscript, Sangamo Biosciences, Lonza Group, Integrated DNA Technologies and New England Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR Genome Editing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Genome Editing.
Report Scope
The CRISPR Genome Editing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR Genome Editing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Genome Editing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics
Segment by Type
Genetic Engineering
Gene Library
Human Stem Cells
Others
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Genome Editing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR.
The global CRISPR Genome Editing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR Genome Editing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR Genome Editing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRISPR Genome Editing in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRISPR Genome Editing include Editas Medicine, CRISPR Therapeutics, Horizon Discovery, Sigma-Aldrich, Genscript, Sangamo Biosciences, Lonza Group, Integrated DNA Technologies and New England Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR Genome Editing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Genome Editing.
Report Scope
The CRISPR Genome Editing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR Genome Editing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Genome Editing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics
Segment by Type
Genetic Engineering
Gene Library
Human Stem Cells
Others
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Genome Editing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Genome Editing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetic Engineering
1.2.3 Gene Library
1.2.4 Human Stem Cells
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Genome Editing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Genome Editing Market Perspective (2019-2030)
2.2 CRISPR Genome Editing Growth Trends by Region
2.2.1 Global CRISPR Genome Editing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR Genome Editing Historic Market Size by Region (2019-2024)
2.2.3 CRISPR Genome Editing Forecasted Market Size by Region (2025-2030)
2.3 CRISPR Genome Editing Market Dynamics
2.3.1 CRISPR Genome Editing Industry Trends
2.3.2 CRISPR Genome Editing Market Drivers
2.3.3 CRISPR Genome Editing Market Challenges
2.3.4 CRISPR Genome Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Genome Editing Players by Revenue
3.1.1 Global Top CRISPR Genome Editing Players by Revenue (2019-2024)
3.1.2 Global CRISPR Genome Editing Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR Genome Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR Genome Editing Revenue
3.4 Global CRISPR Genome Editing Market Concentration Ratio
3.4.1 Global CRISPR Genome Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Genome Editing Revenue in 2023
3.5 CRISPR Genome Editing Key Players Head office and Area Served
3.6 Key Players CRISPR Genome Editing Product Solution and Service
3.7 Date of Enter into CRISPR Genome Editing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Genome Editing Breakdown Data by Type
4.1 Global CRISPR Genome Editing Historic Market Size by Type (2019-2024)
4.2 Global CRISPR Genome Editing Forecasted Market Size by Type (2025-2030)
5 CRISPR Genome Editing Breakdown Data by Application
5.1 Global CRISPR Genome Editing Historic Market Size by Application (2019-2024)
5.2 Global CRISPR Genome Editing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRISPR Genome Editing Market Size (2019-2030)
6.2 North America CRISPR Genome Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR Genome Editing Market Size by Country (2019-2024)
6.4 North America CRISPR Genome Editing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Genome Editing Market Size (2019-2030)
7.2 Europe CRISPR Genome Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR Genome Editing Market Size by Country (2019-2024)
7.4 Europe CRISPR Genome Editing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Genome Editing Market Size (2019-2030)
8.2 Asia-Pacific CRISPR Genome Editing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR Genome Editing Market Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR Genome Editing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Genome Editing Market Size (2019-2030)
9.2 Latin America CRISPR Genome Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR Genome Editing Market Size by Country (2019-2024)
9.4 Latin America CRISPR Genome Editing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Genome Editing Market Size (2019-2030)
10.2 Middle East & Africa CRISPR Genome Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR Genome Editing Market Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR Genome Editing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Editas Medicine
11.1.1 Editas Medicine Company Detail
11.1.2 Editas Medicine Business Overview
11.1.3 Editas Medicine CRISPR Genome Editing Introduction
11.1.4 Editas Medicine Revenue in CRISPR Genome Editing Business (2019-2024)
11.1.5 Editas Medicine Recent Development
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Detail
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics CRISPR Genome Editing Introduction
11.2.4 CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2019-2024)
11.2.5 CRISPR Therapeutics Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery CRISPR Genome Editing Introduction
11.3.4 Horizon Discovery Revenue in CRISPR Genome Editing Business (2019-2024)
11.3.5 Horizon Discovery Recent Development
11.4 Sigma-Aldrich
11.4.1 Sigma-Aldrich Company Detail
11.4.2 Sigma-Aldrich Business Overview
11.4.3 Sigma-Aldrich CRISPR Genome Editing Introduction
11.4.4 Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2019-2024)
11.4.5 Sigma-Aldrich Recent Development
11.5 Genscript
11.5.1 Genscript Company Detail
11.5.2 Genscript Business Overview
11.5.3 Genscript CRISPR Genome Editing Introduction
11.5.4 Genscript Revenue in CRISPR Genome Editing Business (2019-2024)
11.5.5 Genscript Recent Development
11.6 Sangamo Biosciences
11.6.1 Sangamo Biosciences Company Detail
11.6.2 Sangamo Biosciences Business Overview
11.6.3 Sangamo Biosciences CRISPR Genome Editing Introduction
11.6.4 Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2019-2024)
11.6.5 Sangamo Biosciences Recent Development
11.7 Lonza Group
11.7.1 Lonza Group Company Detail
11.7.2 Lonza Group Business Overview
11.7.3 Lonza Group CRISPR Genome Editing Introduction
11.7.4 Lonza Group Revenue in CRISPR Genome Editing Business (2019-2024)
11.7.5 Lonza Group Recent Development
11.8 Integrated DNA Technologies
11.8.1 Integrated DNA Technologies Company Detail
11.8.2 Integrated DNA Technologies Business Overview
11.8.3 Integrated DNA Technologies CRISPR Genome Editing Introduction
11.8.4 Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2019-2024)
11.8.5 Integrated DNA Technologies Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs CRISPR Genome Editing Introduction
11.9.4 New England Biolabs Revenue in CRISPR Genome Editing Business (2019-2024)
11.9.5 New England Biolabs Recent Development
11.10 Origene Technologies
11.10.1 Origene Technologies Company Detail
11.10.2 Origene Technologies Business Overview
11.10.3 Origene Technologies CRISPR Genome Editing Introduction
11.10.4 Origene Technologies Revenue in CRISPR Genome Editing Business (2019-2024)
11.10.5 Origene Technologies Recent Development
11.11 Transposagen Biopharmaceuticals
11.11.1 Transposagen Biopharmaceuticals Company Detail
11.11.2 Transposagen Biopharmaceuticals Business Overview
11.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Introduction
11.11.4 Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2019-2024)
11.11.5 Transposagen Biopharmaceuticals Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific CRISPR Genome Editing Introduction
11.12.4 Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Caribou Biosciences
11.13.1 Caribou Biosciences Company Detail
11.13.2 Caribou Biosciences Business Overview
11.13.3 Caribou Biosciences CRISPR Genome Editing Introduction
11.13.4 Caribou Biosciences Revenue in CRISPR Genome Editing Business (2019-2024)
11.13.5 Caribou Biosciences Recent Development
11.14 Precision Biosciences
11.14.1 Precision Biosciences Company Detail
11.14.2 Precision Biosciences Business Overview
11.14.3 Precision Biosciences CRISPR Genome Editing Introduction
11.14.4 Precision Biosciences Revenue in CRISPR Genome Editing Business (2019-2024)
11.14.5 Precision Biosciences Recent Development
11.15 Cellectis
11.15.1 Cellectis Company Detail
11.15.2 Cellectis Business Overview
11.15.3 Cellectis CRISPR Genome Editing Introduction
11.15.4 Cellectis Revenue in CRISPR Genome Editing Business (2019-2024)
11.15.5 Cellectis Recent Development
11.16 Intellia Therapeutics
11.16.1 Intellia Therapeutics Company Detail
11.16.2 Intellia Therapeutics Business Overview
11.16.3 Intellia Therapeutics CRISPR Genome Editing Introduction
11.16.4 Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2019-2024)
11.16.5 Intellia Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
